rs28997569

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_032043.3(BRIP1):​c.790C>T​(p.Arg264Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00116 in 1,613,856 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R264Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 3 hom. )

Consequence

BRIP1
NM_032043.3 missense

Scores

5
8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:19O:1

Conservation

PhyloP100: 3.66

Publications

26 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, ClinGen
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.041837633).
BP6
Variant 17-61808595-G-A is Benign according to our data. Variant chr17-61808595-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128195.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032043.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRIP1
NM_032043.3
MANE Select
c.790C>Tp.Arg264Trp
missense
Exon 7 of 20NP_114432.2Q9BX63-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRIP1
ENST00000259008.7
TSL:1 MANE Select
c.790C>Tp.Arg264Trp
missense
Exon 7 of 20ENSP00000259008.2Q9BX63-1
BRIP1
ENST00000682453.1
c.790C>Tp.Arg264Trp
missense
Exon 8 of 21ENSP00000506943.1Q9BX63-1
BRIP1
ENST00000683039.1
c.790C>Tp.Arg264Trp
missense
Exon 8 of 21ENSP00000508303.1Q9BX63-1

Frequencies

GnomAD3 genomes
AF:
0.00100
AC:
152
AN:
152004
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000846
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000378
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00143
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000828
AC:
208
AN:
251076
AF XY:
0.000877
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.00114
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00118
AC:
1719
AN:
1461734
Hom.:
3
Cov.:
31
AF XY:
0.00117
AC XY:
853
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33478
American (AMR)
AF:
0.000514
AC:
23
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00253
AC:
66
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000243
AC:
21
AN:
86254
European-Finnish (FIN)
AF:
0.000393
AC:
21
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00134
AC:
1490
AN:
1111880
Other (OTH)
AF:
0.00124
AC:
75
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
104
208
313
417
521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000999
AC:
152
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.000833
AC XY:
62
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.000844
AC:
35
AN:
41486
American (AMR)
AF:
0.000785
AC:
12
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000378
AC:
4
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00143
AC:
97
AN:
67990
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
0
Bravo
AF:
0.00101
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000708
AC:
86
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00113

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Familial cancer of breast (4)
-
1
3
Hereditary cancer-predisposing syndrome (4)
-
-
4
not provided (4)
-
1
2
not specified (4)
-
1
1
Fanconi anemia complementation group J (2)
-
-
2
Malignant tumor of breast (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
BRIP1-related disorder (1)
-
-
1
Familial cancer of breast;C1836860:Fanconi anemia complementation group J (1)
-
-
1
Ovarian cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.12
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.77
D
Eigen
Pathogenic
0.71
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.042
T
MetaSVM
Uncertain
-0.0027
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
3.7
PrimateAI
Benign
0.42
T
PROVEAN
Pathogenic
-5.8
D
REVEL
Uncertain
0.34
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.55
MVP
0.96
MPC
0.67
ClinPred
0.032
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.56
gMVP
0.72
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28997569; hg19: chr17-59885956; COSMIC: COSV52000602; API